HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Greater uptake, education needed to realize cost-saving potential of biosimilars John DeRosier
-
- Should prices of biosimilars be regulated in the US?
- Late effects of Hodgkin lymphoma treatment: We can still do better John Sweetenham, MD, FRCP, FACP
- Determining when it is your time to retire Nicholas J. Petrelli, MD, FACS
- Reflections on the pandemic: Flexibility ‘a must’ for palliative care nurse practitioners Brighton Loveday, ANP-BC, AOCNP, ACHPN, APRN
- Palliative care amid COVID-19: ‘Be seen, heard and flexible’ Jennifer Byrne
- ASCO-ACCC collaboration aims to make clinical trial diversity ‘part of our DNA’ Mark Leiser
- Study to yield ‘deeper insights’ into COVID-19’s impact on cancer care in Latin America Jennifer R. Southall
- Radiotherapy fails to extend DFS after complete resection in NSCLC Jennifer R. Southall
-
- Sacituzumab govitecan improves survival in pretreated triple-negative breast cancer Jennifer R. Southall
- Acalabrutinib appears effective, safe for advanced CLL Mark Leiser
- Ponatinib starting dose may be linked to efficacy, safety in chronic-phase CML John DeRosier
- HIV status does not affect outcomes in advanced classical Hodgkin lymphoma Mark Leiser
- Ixazomib regimen fails to extend PFS in transplant-ineligible multiple myeloma Mark Leiser
- Fludarabine-busulfan regimen confers favorable long-term outcomes in myelofibrosis Drew Amorosi
- Researchers describe impact of SF3B1 mutations in myelodysplastic syndrome John DeRosier
- COVID-19-related surgical delays for early breast cancer may not affect OS, data suggest John DeRosier
-
- BIVV001 effective, safe in severe hemophilia A John DeRosier
- Non-small cell lung cancer mortality rates decline sharply amid advances in treatment John DeRosier
- Addition of cetuximab to chemotherapy shortens OS in advanced colorectal cancer subset Jennifer R. Southall
- Top-ranked cancer centers superior to affiliates in survival outcomes Jennifer R. Southall
- FDA identifies more cases of lymphoma linked to breast implants
- FDA approves Phesgo, at-home treatment regimen for breast cancer
- FDA issues alert about use of Tecentriq with paclitaxel for breast cancer
- FDA approves Foundation Medicine pan-tumor liquid biopsy test
-
- Hematology/oncology drugs receive priority review
- Hematology/oncology institutions, practices announce faculty promotions, additions